Drug patent extension is about to be back in the news with Merck's subcutaneous pembro announcement.

Here's some background on how patent extenders work and how common this is for 'blockbuster' drugs (72%!): https://academic.oup.com/jlb/article/5/3/590/5232981
#HealthPolicy #MedSky #OncSky #PharmSky
1 / 2
Post image
Post image

Comments

Posting Rules

  • Be respectful to others
  • No spam or self-promotion
  • Stay on topic
  • Follow Bluesky's terms of service